Llanos, Anastacio C.
HRN: 22-55-99 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/12/2023
METRONIDAZOLE 500MG (TAB)
02/12/2023
02/19/2023
PER NGT
500mg
Q6
Tetanus Infection
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamCentral Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes